Has Bhuvanaprasad Mandalapu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,467 in general payments to Bhuvanaprasad Mandalapu, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bhuvanaprasad Mandalapu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bhuvanaprasad Mandalapu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bhuvanaprasad Mandalapu, MD

Neurology · Mount Vernon, WANPI 1881639581

Payments from drug & device makers

$2,467in general payments, 2019–2025

Across 45 payments — averaging $54.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$1K
AbbVie$231
Abbott$206
Inspire Medical Systems, Inc.$140
Novartis$52
Teva Pharmaceuticals USA, Inc.$52
plus $413 from 14 others

What the payments were for

Travel & lodging$1,09444%
Food & beverage$1,37356%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	4	$1,372
AbbVie	11	$231
Abbott	8	$206
Inspire Medical Systems, Inc.	1	$140
Novartis	2	$52
Teva Pharmaceuticals USA, Inc.	1	$52
EMD Serono, Inc.	1	$49
Genentech USA, Inc.	2	$43
Otsuka America Pharmaceutical, Inc.	2	$42
Mallinckrodt Hospital Products Inc.	2	$38
Biogen	1	$34
Axsome Therapeutics, Inc.	2	$29
Springworks Therapeutics, Inc.	1	$29
Neurocrine Biosciences, Inc.	1	$27
Jazz Pharmaceuticals Inc.	1	$26
Lundbeck LLC	1	$24
Acadia Pharmaceuticals Inc	1	$22
Sunovion Pharmaceuticals Inc.	1	$17
Tanabe Pharma America, Inc.	1	$17
Harmony Biosciences LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VNS Therapy$1,372
Inspire$140

How this compares

$2,467 in reported general payments places this provider in the 70th percentile of 418 neurology providers in Washington.

See all neurology providers in Washington →

Medicare billing

Part B allowed, 2024

$77,494

Medicare patients

373

Services billed

3,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BriviactBrivaracetam	13	$29,299
Nurtec OdtRimegepant Sulfate	19	$26,602
Emgality PenGalcanezumab-Gnlm	12	$9,273
Lacosamide	20	$4,048
Memantine Hcl	88	$3,124
Levetiracetam	71	$3,095
Donepezil Hcl	116	$1,604
Divalproex Sodium	36	$1,528
Entacapone	15	$1,490
Carbidopa-Levodopa ErCarbidopa/Levodopa	19	$1,287
Carbidopa-LevodopaCarbidopa/Levodopa	73	$1,253
Quetiapine Fumarate	17	$1,100
Valproic AcidValproic Acid (As Sodium Salt)	16	$1,071
Divalproex Sodium ErDivalproex Sodium	16	$1,042
Primidone	52	$966

Paid to pharmacies, not to this prescriber.

Other neurology in Mount Vernon

Amir MazhariMount Vernon$312K
Jason AldredSpokane$9.5M
David GreeleySpokane$8.5M
Pinky AgarwalKirkland$5.4M
Pavle RepovicSeattle$4.8M
James BowenKirkland$2.3M
Michael RosenbloomSeattle$1.8M
Stacy DonlonTacoma$1.7M
Patrick HoganTacoma$1.1M
Daniel BurdickKirkland$1M

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →